FIA
SRNE

FNY Investment Advisers’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

FNY Investment Advisers’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-300
Closed -$1K – 654
2020
Q2 		$1K Buy
+300
New +$1.15K ﹤0.01% 394
2019
Q4 		– Sell
-2,000
Closed -$4K – 1134
2019
Q3 		$4K Buy
+2,000
New +$4.66K ﹤0.01% 677

Other funds holding SRNE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

FNY Investment Advisers's SRNE Position: Q3 2020 in Review

FNY Investment Advisers sold out of Sorrento Therapeutics, Inc. (SRNE) in Q3 2020, closing a stake of 300 shares — an estimated $1K sold.

FNY Investment Advisers first reported a position in SRNE in Q3 2019 and held it in 2 quarters. The position peaked at $4K in Q3 2019. 209 funds tracked by Wall St. Rank hold SRNE as of Q3 2020.

  • FNY Investment Advisers reported no remaining Sorrento Therapeutics, Inc. position as of Q3 2020 after selling out during the quarter.
  • FNY Investment Advisers sold 300 Sorrento Therapeutics, Inc. shares in Q3 2020, an estimated $1K.
  • FNY Investment Advisers first reported a position in Sorrento Therapeutics, Inc. in Q3 2019 and held it in 2 quarters.
  • FNY Investment Advisers's Sorrento Therapeutics, Inc. position peaked at $4K in Q3 2019.
  • 209 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q3 2020.

Based on FNY Investment Advisers's 13F filing for Q3 2020, filed 9 Oct 2020.